14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Thursday, 27th Jul 2023 IMV stock ended at $0.82. During the day the stock fluctuated 0% from a day low at $0.82 to a day high of $0.82.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical IMV Inc. prices

Date Open High Low Close Volume
Jul 27, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 26, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 25, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 24, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 21, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 20, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 19, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 18, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 17, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 14, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 13, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 12, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 11, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 10, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 07, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 06, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 05, 2023 $0.82 $0.82 $0.82 $0.82 0
Jul 03, 2023 $0.82 $0.82 $0.82 $0.82 0
Jun 30, 2023 $0.82 $0.82 $0.82 $0.82 0
Jun 29, 2023 $0.82 $0.82 $0.82 $0.82 0
Jun 28, 2023 $0.82 $0.82 $0.82 $0.82 0
Jun 27, 2023 $0.82 $0.82 $0.82 $0.82 0
Jun 26, 2023 $0.82 $0.82 $0.82 $0.82 0
Jun 23, 2023 $0.82 $0.82 $0.82 $0.82 0
Jun 22, 2023 $0.82 $0.82 $0.82 $0.82 0
Click to get the best stock tips daily for free!

About IMV Inc.

IMV. IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and micr... IMV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT